Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand

被引:500
作者
Ito, Tomoki
Yang, Maria
Wang, Yui-Hsi
Lande, Roberto
Gregorio, Josh
Perng, Olivia A.
Qin, Xiao-Feng
Liu, Yong-Jun
Gilliet, Michel
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
[2] Univ Texas, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA
关键词
D O I
10.1084/jem.20061660
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although there is evidence for distinct roles of myeloid dendritic cells (DCs [mDCs]) and plasmacytoid pre-DCs (pDCs) in regulating T cell-mediated adaptive immunity, the concept of functional DC subsets has been questioned because of the lack of a molecular mechanism to explain these differences. In this study, we provide direct evidence that maturing mDCs and pDCs express different sets of molecules for T cell priming. Although both maturing mDCs and pDCs upregulate the expression of CD80 and CD86, only pDCs upregulate the expression of inducible costimulator ligand (ICOS-L) and maintain high expression levels upon differentiation into mature DCs. High ICOS-L expression endows maturing pDCs with the ability to induce the differentiation of naive CD4 T cells to produce interleukin-10 (IL-10) but not the T helper (Th) 2 cytokines IL-4, -5, and -13. These IL-10-producing T cells are T regulatory cells, and their generation by ICOS-L is independent of pDC-driven Th1 and Th2 differentiation, although, in the later condition, some contribution from endogenous IL-4 cannot be completely ruled out. Thus, in contrast to mDCs, pDCs are poised to express ICOS-L upon maturation, which leads to the generation of IL-10 producing T regulatory cells. Our findings demonstrate that mDC and pDCs are intrinsically different in the expression of costimulatory molecules that drive distinct types of T cell responses.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 57 条
[1]  
Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
[2]   Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes [J].
Baldwin, T ;
Henri, S ;
Curtis, J ;
O'Keeffe, M ;
Vremec, D ;
Shortman, K ;
Handman, E .
INFECTION AND IMMUNITY, 2004, 72 (04) :1991-2001
[3]  
Beier KC, 2000, EUR J IMMUNOL, V30, P3707, DOI 10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO
[4]  
2-Q
[5]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[6]   Interleukin-10 regulation in normal subjects and patients with asthma [J].
Borish, L ;
Aarons, A ;
Rumbyrt, J ;
Cvietusa, P ;
Negri, J ;
Wenzel, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) :1288-1296
[7]   Maturation, activation, and protection of dendritic cells induced by double-stranded RNA [J].
Cella, M ;
Salio, M ;
Sakakibara, Y ;
Langen, H ;
Julkunen, I ;
Lanzavecchia, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :821-829
[8]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226
[9]   Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen [J].
de Heer, HJ ;
Hammad, H ;
Soullié, T ;
Hijdra, D ;
Vos, N ;
Willart, MAM ;
Hoogsteden, HC ;
Lambrecht, BN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :89-98
[10]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238